Patents by Inventor Xuejun Wu
Xuejun Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240131205Abstract: The present disclosure relates to the fields of nuclear medicine and molecular imaging, and specifically relates to a dual-targeting compound and a preparation method and application thereof. The dual-targeting compound has the following structure shown in Formula (I). The present disclosure also provides a dual-targeting compound capable of being labeled with a radionuclide, and the compound has the following structure shown in Formula (I-1) or Formula (I-2). The dual-targeting compound of the present disclosure has high affinity for an FAP target and an integrin ?v?3 target, can realize synergistic targeting of the FAP target and the integrin ?v?3 target in tumors, and has high uptake in tumors and long retention time in tumors.Type: ApplicationFiled: December 9, 2022Publication date: April 25, 2024Inventors: Xiaoyuan CHEN, Pengfei XU, Xiaoming WU, Zhide GUO, Qingbao YANG, Xuejun WEN
-
Patent number: 11928485Abstract: A data transmission method includes: displaying a target message in a session interface; in response to a trigger operation on the target message, outputting a resource transmission interface including an object display region and an icon display region; and the object display region including an object identifier of at least one transmission object, and the icon display region including a message icon corresponding to the target message; moving the message icon from the icon display region to the object display region according to a moving operation on the message icon; and transmitting, in response to the message icon being moved to the object display region, the data resource to a target transmission object of the at least one transmission object in the object display region, the target transmission object being determined according to an ending position of a movement track of the message icon corresponding to the moving operation.Type: GrantFiled: October 12, 2022Date of Patent: March 12, 2024Assignee: TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITEDInventors: Zhiying Wu, Xuejun Sun, Jinhui Chen
-
Patent number: 11467836Abstract: An acceleration unit including a primary core and a secondary core is provided. The primary core includes a first on-chip memory, a primary core sequencer adapted to decode a received first cross-core copy instruction, and a primary core memory copy engine adapted to acquire a first operand from a first address in the first on-chip memory and copy the acquired first operand to a second address in a second on-chip memory of the secondary core. Further, the secondary core includes a second on-chip memory, a secondary core sequencer adapted to decode a received second cross-core copy instruction, and a secondary core memory copy engine adapted to acquire the first operand from the second address in the second on-chip memory and copy the acquired first operand back to the first address in the first on-chip memory.Type: GrantFiled: January 26, 2021Date of Patent: October 11, 2022Assignee: Alibaba Group Holding LimitedInventors: Jun He, Li Yin, Xuejun Wu
-
Publication number: 20210255866Abstract: An acceleration unit including a primary core and a secondary core. The primary core includes: a first on-chip memory; a primary core sequencer adapted to decode a received first cross-core copy instruction; and a primary core memory copy engine adapted to acquire a first operand from a first address in the first on-chip memory and copy the acquired first operand to a second address in a second on-chip memory of the secondary core. The secondary core includes: a second on-chip memory; a secondary core sequencer adapted to decode a received second cross-core copy instruction; and a secondary core memory copy engine adapted to acquire the first operand from the second address in the second on-chip memory and copy the acquired first operand back to the first address in the first on-chip memory.Type: ApplicationFiled: January 26, 2021Publication date: August 19, 2021Inventors: Jun HE, Li YIN, Xuejun WU
-
Patent number: 10428013Abstract: Disclosed are amide compounds, preparation method and uses thereof, specifically, the compounds represented by formula I or pharmaceutically acceptable salts, wherein R1, R2, R3, R4, R5, Q, X and n are defined as in the description. Also disclosed are a method for preparing the compounds of formula I, a composition containing the compounds, and the uses of the same in the preparation of medicaments for regulating blood lipid and/or preventing gallstone. The compounds of formula I disclosed in the present invention have stability in vitro, good solubility in the pharmaceutical organic solvents and favorable bioavailability in animals.Type: GrantFiled: June 25, 2012Date of Patent: October 1, 2019Assignees: Shanghai Institute of Phamaceutical Industry, China State Institute of Pharmaceutical IndustryInventors: Zhenpeng Yu, Gouping Wang, Zhen Zhang, Minyu Liu, Xiaoling Huang, Ying Liu, Lin Xiao, Li Cai, Xuejun Wu, Yifang Deng, Mianli Pan, Renhai Chen, Shenrong Tang, Quanhai Liu
-
Patent number: 9712374Abstract: In general, the invention is directed to techniques for scheduling resource access within an intermediate network device. For example, as described herein, a device receives packets for a plurality of sessions that include application-layer data for the sessions. The device determines a weight for each of the plurality of sessions and, during periods of resource congestion, selects one or more sessions for additional resource allocation based on the respective weights of the sessions. The device allocates additional memory resources to selected sessions to enable further buffering of application-layer data such that the device may apply the service to multiple sessions concurrently despite the resource congestion.Type: GrantFiled: August 18, 2010Date of Patent: July 18, 2017Assignee: Juniper Networks, Inc.Inventors: Wei Cao, Xia Zhu, Xuejun Wu
-
Patent number: 8962880Abstract: An amorphous asiatic tromethamine salt and the preparation method thereof. The method includes the steps of: (1) dissolving asiatic acid in an organic solvent; step (2) mixing with tromethamine; step (3) stirring and salifying the same, and then removing the organic solvent. The method for preparing the amorphous asiatic tromethamine salt is easy and effective, and the water solubility and bioavailability of the asiatic tromethamine salt thus obtained are greatly compared with the prior art.Type: GrantFiled: March 21, 2012Date of Patent: February 24, 2015Assignee: Shanghai Institute of Pharmaceutical IndustryInventors: Guobin Ren, Ying Liu, Jinyao Chen, Xiaoling Huang, Lin Xiao, Li Cai, Zhen Zhang, Xuejun Wu, Haiyan Sun, Quanhai Liu, Liling Jin, Minyu Liu, Yifang Deng, Zhiru Xu, Renhai Chen, Chungang Li, Xiangduan Tan, Yan Qin
-
Publication number: 20140243553Abstract: An amorphous asiatic tromethamine salt and the preparation method thereof. The method includes the steps of: (1) dissolving asiatic acid in an organic solvent; step (2) mixing with tromethamine; step (3) stirring and salifying the same, and then removing the organic solvent. The method for preparing the amorphous asiatic tromethamine salt is easy and effective, and the water solubility and bioavailability of the asiatic tromethamine salt thus obtained are greatly compared with the prior art.Type: ApplicationFiled: March 21, 2012Publication date: August 28, 2014Applicant: SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRYInventors: Guobin Ren, Ying Liu, Jinyao Chen, Xiaoling Huang, Lin Xiao, Li Cai, Zhen Zhang, Xuejun Wu, Haiyan Sun, Quanhai Liu, Liling Jin, Minyu Liu, Yifang Deng, Zhiru Xu, Renhai Chen, Chungang Li, Xiangduan Tan, Yan Qin
-
Publication number: 20140128463Abstract: Disclosed are amide compounds, preparation method and uses thereof, specifically, the compounds represented by formula I or pharmaceutically acceptable salts, wherein R1, R2, R3, R4, R5, Q, X and n are defined as in the description. Also disclosed are a method for preparing the compounds of formula I, a composition containing the compounds, and the uses of the same in the preparation of medicaments for regulating blood lipid and/or preventing gallstone. The compounds of formula I disclosed in the present invention have stability in vitro, good solubility in the pharmaceutical organic solvents and favorable bioavailability in animals.Type: ApplicationFiled: June 25, 2012Publication date: May 8, 2014Applicants: China State Institute of Pharmaceutic Industry, Shanghai Institute of Pharmaceutical IndustryInventors: Zhenpeng Yu, Gouping Wang, Zhen Zhang, Minyu Liu, Xiaoling Huang, Ying Liu, Lin Xiao, Li Cai, Xuejun Wu, Yifang Deng, Mianli Pan, Renhai Chen, Shenrong Tang, Quanhai Liu
-
Patent number: 8258176Abstract: The invention discloses a dithiolopyrrolone compound represented by formula I or its pharmaceutically acceptable salts, wherein X1, R1, R2, R3, R4 are defined as in the description. The invention also discloses the preparation of such compounds, and the use of such compounds in preparation of medicaments for increasing peripheral white blood cells and in preparation of ancillary medicaments for inhibiting the decrease of peripheral white blood cells in radiotherapy or chemotherapy.Type: GrantFiled: August 29, 2008Date of Patent: September 4, 2012Assignees: Shanghai Institute of Pharmaceutical Industry, Shanghai Modern Pharmaceutical Co., Ltd.Inventors: Guoping Wang, Quanhai Liu, Haiyan Sun, Wei Wu, Jian Hou, Lin Yao, Chungang Li, Minyu Liu, Fei Li, Xuejun Wu, Shuai Zhao
-
Patent number: 8261352Abstract: A method includes receiving a data unit, determining whether a current state, associated with a deterministic finite automata (DFA) that includes a portion of states in a bitmap and a remaining portion of states in a DFA table, is a bitmap state or not, and determining whether a value corresponding to the data unit is greater than a threshold value, when it is determined that the current state is not a bitmap state. The method further includes determining whether the current state is insensitive, when it is determined that the value corresponding to the data unit is greater than the threshold value, where insensitive means that each next state is a same state for the current state, and selecting a default state, as a next state for the current, when it is determined that the current state is insensitive.Type: GrantFiled: May 19, 2009Date of Patent: September 4, 2012Assignee: Juniper Networks Inc.Inventors: Qingming Ma, Bryan Burns, Sheng Li, Na Liu, Xuejun Wu, Shan Yu, Li Zheng
-
Publication number: 20100229238Abstract: A method includes receiving a data unit, determining whether a current state, associated with a deterministic finite automata (DFA) that includes a portion of states in a bitmap and a remaining portion of states in a DFA table, is a bitmap state or not, and determining whether a value corresponding to the data unit is greater than a threshold value, when it is determined that the current state is not a bitmap state. The method further includes determining whether the current state is insensitive, when it is determined that the value corresponding to the data unit is greater than the threshold value, where insensitive means that each next state is a same state for the current state, and selecting a default state, as a next state for the current, when it is determined that the current state is insensitive.Type: ApplicationFiled: May 19, 2009Publication date: September 9, 2010Applicant: Juniper Networks Inc.Inventors: Qingming Ma, Bryan Burns, Sheng Li, Na Liu, Xuejun Wu, Shan Yu, Li Zheng
-
Publication number: 20100210856Abstract: The invention discloses a dithiolopyrrolone compound represented by formula I or its pharmaceutically acceptable salts, wherein X1, R1, R2, R3, R4 are defined as in the description. The invention also discloses the preparation of such compounds, and the use of such compounds in preparation of medicaments for increasing peripheral white blood cells and in preparation of ancillary medicaments for inhibiting the decrease of peripheral white blood cells in radiotherapy or chemotherapy.Type: ApplicationFiled: August 29, 2008Publication date: August 19, 2010Applicants: SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY, SHANGHAI MODERN PHARMACEUTICAL CO., LTDInventors: Guoping Wang, Quanhai Liu, Haiyan Sun, Wei Wu, Jian Hou, Lin Yao, Chungang Li, Minyu Liu, Fei Li, Xuejun Wu, Shuai Zhao
-
Patent number: 6867194Abstract: Sugar-modified SIN-1 compositions are provided. The compositions are useful for generating NO in response to hydrolytic activity of a glycosidase specific for the O-glycosidic bond between the sugar and SIN-1 moieties. Pharmaceutical compositions containing the sugar-modified SIN-1 compositions and methods of using the compositions are also provided.Type: GrantFiled: August 9, 2001Date of Patent: March 15, 2005Assignee: Wayne State UniversityInventors: Peng George Wang, Xuejun Wu, Xiaoping Tang
-
Publication number: 20030050256Abstract: Sugar-modified SIN-1 compositions are provided. The compositions are useful for generating NO in response to hydrolytic activity of a glycosidase specific for the O-glycosidic bond between the sugar and SIN-1 moieties. Pharmaceutical compositions containing the sugar-modified SIN-1 compositions and methods of using the compositions are also provided.Type: ApplicationFiled: August 9, 2001Publication date: March 13, 2003Inventors: Peng George Wang, Xuejun Wu, Xiaoping Tang